Global Alpha Emitters Market to Grow by 35.82% Annually Through 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 31, 2022--

The "Alpha Emitters Market Analysis, By Radionuclide Type (Bismuth, Astatine, Radium), By Medical Application, By End User, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The alpha emitters market size is estimated to be USD 698.3 million in 2021 and is expected to witness a CAGR of 35.82% during the forecast period 2022-2029. The increased public knowledge of the potential advantages of targeted alpha emitters and the prevalence of several malignancies, including ovarian, pancreatic, lymphoma, and melanoma are factors contributing to the market growth. However, stringent regulatory requirement is expected to hinder the growth.

Segmentation: Alpha Emitters Market Report 2021-2029

Radionuclide Type (Revenue, USD Million)

• Bismuth (Bi-212)
• Astatine (At-211)
• Radium (Ra-223)
• Actinium (Ac-225)
• Bismuth (Bi -213)
• Lead (Pb-212)
• Terbium (Tb-149)

Medical Application (Revenue, USD Million)

• Pancreatic Cancer
• Prostate Cancer
• Endocrine Tumors
• Ovarian Cancer
• Bone Metastases
• Others

End user (Revenue, USD Million)

• Clinics
• Hospitals
• Research Laboratories

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Alpha Emitters

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Alpha Emitters Market

7. Market Analysis by Radionuclide Type

8. Market Analysis by Medical Application

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Alpha Emitters Market

12. Europe Alpha Emitters Market

13. Asia Pacific Alpha Emitters Market

14. Latin America Alpha Emitters Market

15. MEA Alpha Emitters Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion & Recommendations

Companies Mentioned

• Bracco Imaging (Italy)
• Eczacyba ş y-Monrol Nuclear Products (Turkey)
• Nordion (Canada)
• GE Healthcare (US)
• Advanced Accelerator Applications (France)
• Lantheus Medical Imaging (US)
• NTP Radioisotopes (South Africa)
• Curium (France)
• JSC Isotope (Russia)
• Cardinal Health (US)
• Bayer AG (Germany)
• NorthStar Medical Radioisotopes (US)
• Eckert & Ziegler (Germany)

For more information about this report visit https://www.researchandmarkets.com/r/78tbtz

View source version on businesswire.com:https://www.businesswire.com/news/home/20221031005372/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.